Regulation of the pharmaceutical industry: promoting health or protecting wealth?

Posted on by Corporations and Health Watch

Government has long had conflicting aims with regard to regulating the pharmaceutical industry. An essay in the in the Journal of the Royal Society of Medicine asks how the National Health Service in the United Kingdom is balancing its public health and economic mandates.

Leave a Reply

Fill in your details below or click an icon to log in:

Gravatar
WordPress.com Logo

You are commenting using your WordPress.com account. ( Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. ( Log Out /  Change )

Cancel

Connecting to %s